IVVD in the 13F filings
Adagio Therapeutics Inc · CUSIP 00534A102
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 19 Feb 2026
- latest of these filings; the earliest 12 Feb 2026
- Managers listing it
- 16
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 1 listed it in both
- Shares listed
- 79,607,971
- combined, among listed positions
- Reported value
- $197m
- combined, at the quarter end
Among the 92 comparable managers: 11 buyers (opened or added shares) and 5 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +11,872,456.
Managers listing IVVD in Q4 2025
16 of 16 holders
Largest increases and reductions, by shares
Increases
- Janus Henderson Group Ltdexisting position · 32,543,142 shares now+7,160,065
- Balyasny Asset Management LLCnew position · 3,806,976 shares now+3,806,976
- Two Sigma Investments LPexisting position · 2,191,900 shares now+1,856,900
- Renaissance Technologies LLCnew position · 1,026,620 shares now+1,026,620
- Two Sigma Advisers LPnew position · 916,600 shares now+916,600
Reductions
- Point72 Asset Management LPexisting position · 16,653,036 shares now-3,649,064
- Jane Street Group LLCexisting position · 513,863 shares now-251,580
- Millennium Management LLCexisting position · 1,286,455 shares now-160,160
- Fidelity (FMR LLC)existing position · 141,939 shares now-1,035
New positions and exits
New (6)
Exited (1)
- AQR Capital Management LLCwas $43k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2021 | 3 | $670m | n.a. | n.a. |
| Q1 2022 | 1 | $4.5m | n.a. | n.a. |
| Q1 2023 | 1 | $2.3m | n.a. | n.a. |
| Q2 2023 | 1 | $2.5m | n.a. | n.a. |
| Q3 2023 | 1 | $9.0m | n.a. | n.a. |
| Q4 2023 | 1 | $37m | 1 | 0 |
| Q1 2024 | 1 | $52m | 1 | 0 |
| Q2 2024 | 1 | $13m | 0 | 0 |
| Q3 2024 | 1 | $12m | 0 | 0 |
| Q4 2024 | 1 | $5.2m | 0 | 0 |
| Q1 2025 | 1 | $6.6m | 0 | 1 |
| Q2 2025 | 1 | $7.3m | 0 | 1 |
| Q3 2025 | 1 | $21m | 1 | 0 |
| Q4 2025 | 3 | $169m | 11 | 5 |
| Q1 2026 | 2 | $68m | 14 | 5 |
| Q2 2026 | 1 | $17m | 9 | 12 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
IVVD and GILD →IVVD and AMGN →IVVD and ARGX →Choose a stock to compare with IVVD →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own IVVD, latest filings →Back to the 13F Explorer →